Head-to-head · Cost-Efficiency Index
EverSlim vs Maves
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
EverSlim
Cost-first shoppers who want flat-price compounded glp-1 care shipped nationwide.
Visit EverSlimMaves
Shoppers drawn to aggressive low intro pricing on semaglutide who will confirm the exact charge before checkout.
Visit MavesThe verdict
EverSlim and Maves tie on the Cost-Efficiency Index at 76/100, so neither wins outright on the numbers. For most shoppers we'd start with EverSlim (ranked #48, a hair above #49) — Cost-first shoppers who want flat-price compounded glp-1 care shipped nationwide. But Maves is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs EverSlim.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | EverSlim | Maves |
|---|---|---|
| Cost-Efficiency Index | 76/100 | 76/100 |
| Semaglutide / mo | $117/mo (compounded) | $89/mo (starting dose, compounded) |
| Tirzepatide / mo | $140/mo (compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $1,404 | $1,068 |
| Tirzepatide / yr (modeled) | $1,680 | — |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #48 | #49 |
EverSlim
76/100Where the value is
- Transparent flat pricing from 127 dollars a month for compounded semaglutide; medication, provider visit, and shipping included with no insurance.
- Names its pharmacy partners (EPIQ Scripts, Foothills, Emerald) and DrTelx medical group; LegitScript-approved and NABP-accredited.
- Available in all 50 states and DC, with asynchronous care in 44 states and live-visit access in the rest.
The tradeoffs
- No price tiers are published anywhere: /pricing is a 404, the footer pricing link is a same-page anchor, and the checkout is behind a login, so what a titrated dose costs is unknowable before signing up
- Cancellation requires at least 72 hours' notice before the next billing date, or the subscription renews for another cycle
Maves
76/100Where the value is
- LegitScript badge displayed on the site
- Publishes the FDA compounded-medication disclaimer
- Low advertised semaglutide entry price ($89-99/mo range)
The tradeoffs
- The homepage shows two different numbers for the same starting semaglutide tier ($89/month vs $99 first month) with no reconciliation — the real ongoing price cannot be confirmed from the public site
- Tirzepatide is listed as an offering but no price is published anywhere reachable on the site, confirmed by direct search
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.